Points to consider in cardiovascular disease risk management among patients with rheumatoid arthritis living in South Africa, an unequal middle income country

Abstract Background It is plausible that optimal cardiovascular disease (CVD) risk management differs in patients with rheumatoid arthritis (RA) from low or middle income compared to high income populations. This study aimed at producing evidence-based points to consider for CVD prevention in South...

Full description

Bibliographic Details
Main Authors: Ahmed Solomon, Anne E. Stanwix, Santos Castañeda, Javier Llorca, Carlos Gonzalez-Juanatey, Bridget Hodkinson, Benitha Romela, Mahmood M. T. M. Ally, Ajesh B. Maharaj, Elsa M. Van Duuren, Joyce J. Ziki, Mpoti Seboka, Makgotso Mohapi, Barend J. Jansen Van Rensburg, Gareth S. Tarr, Kavita Makan, Charlene Balton, Aphrodite Gogakis, Miguel A. González-Gay, Patrick H. Dessein
Format: Article
Language:English
Published: BMC 2020-06-01
Series:BMC Rheumatology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s41927-020-00139-2
id doaj-c93769aa79ee4d97abc50cc901e11eaf
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Ahmed Solomon
Anne E. Stanwix
Santos Castañeda
Javier Llorca
Carlos Gonzalez-Juanatey
Bridget Hodkinson
Benitha Romela
Mahmood M. T. M. Ally
Ajesh B. Maharaj
Elsa M. Van Duuren
Joyce J. Ziki
Mpoti Seboka
Makgotso Mohapi
Barend J. Jansen Van Rensburg
Gareth S. Tarr
Kavita Makan
Charlene Balton
Aphrodite Gogakis
Miguel A. González-Gay
Patrick H. Dessein
spellingShingle Ahmed Solomon
Anne E. Stanwix
Santos Castañeda
Javier Llorca
Carlos Gonzalez-Juanatey
Bridget Hodkinson
Benitha Romela
Mahmood M. T. M. Ally
Ajesh B. Maharaj
Elsa M. Van Duuren
Joyce J. Ziki
Mpoti Seboka
Makgotso Mohapi
Barend J. Jansen Van Rensburg
Gareth S. Tarr
Kavita Makan
Charlene Balton
Aphrodite Gogakis
Miguel A. González-Gay
Patrick H. Dessein
Points to consider in cardiovascular disease risk management among patients with rheumatoid arthritis living in South Africa, an unequal middle income country
BMC Rheumatology
Cardiovascular disease risk management
Rheumatoid arthritis
Low to middle income countries
South Africa
author_facet Ahmed Solomon
Anne E. Stanwix
Santos Castañeda
Javier Llorca
Carlos Gonzalez-Juanatey
Bridget Hodkinson
Benitha Romela
Mahmood M. T. M. Ally
Ajesh B. Maharaj
Elsa M. Van Duuren
Joyce J. Ziki
Mpoti Seboka
Makgotso Mohapi
Barend J. Jansen Van Rensburg
Gareth S. Tarr
Kavita Makan
Charlene Balton
Aphrodite Gogakis
Miguel A. González-Gay
Patrick H. Dessein
author_sort Ahmed Solomon
title Points to consider in cardiovascular disease risk management among patients with rheumatoid arthritis living in South Africa, an unequal middle income country
title_short Points to consider in cardiovascular disease risk management among patients with rheumatoid arthritis living in South Africa, an unequal middle income country
title_full Points to consider in cardiovascular disease risk management among patients with rheumatoid arthritis living in South Africa, an unequal middle income country
title_fullStr Points to consider in cardiovascular disease risk management among patients with rheumatoid arthritis living in South Africa, an unequal middle income country
title_full_unstemmed Points to consider in cardiovascular disease risk management among patients with rheumatoid arthritis living in South Africa, an unequal middle income country
title_sort points to consider in cardiovascular disease risk management among patients with rheumatoid arthritis living in south africa, an unequal middle income country
publisher BMC
series BMC Rheumatology
issn 2520-1026
publishDate 2020-06-01
description Abstract Background It is plausible that optimal cardiovascular disease (CVD) risk management differs in patients with rheumatoid arthritis (RA) from low or middle income compared to high income populations. This study aimed at producing evidence-based points to consider for CVD prevention in South African RA patients. Methods Five rheumatologists, one cardiologist and one epidemiologist with experience in CVD risk management in RA patients, as well as two patient representatives, two health professionals and one radiologist, one rheumatology fellow and 11 rheumatologists that treat RA patients regularly contributed. Systematic literature searches were performed and the level of evidence was determined according to standard guidelines. Results Eighteen points to consider were formulated. These were grouped into 6 categories that comprised overall CVD risk assessment and management (n = 4), and specific interventions aimed at reducing CVD risk including RA control with disease modifying anti-rheumatic drugs, glucocorticoids and non-steroidal anti-inflammatory drugs (n = 3), lipid lowering agents (n = 8), antihypertensive drugs (n = 1), low dose aspirin (n = 1) and lifestyle modification (n = 1). Each point to consider differs partially or completely from recommendations previously reported for CVD risk management in RA patients from high income populations. Currently recommended CVD risk calculators do not reliably identify South African black RA patients with very high-risk atherosclerosis as represented by carotid artery plaque presence on ultrasound. Conclusions Our findings indicate that optimal cardiovascular risk management likely differs substantially in RA patients from low or middle income compared to high income populations. There is an urgent need for future multicentre longitudinal studies on CVD risk in black African patients with RA.
topic Cardiovascular disease risk management
Rheumatoid arthritis
Low to middle income countries
South Africa
url http://link.springer.com/article/10.1186/s41927-020-00139-2
work_keys_str_mv AT ahmedsolomon pointstoconsiderincardiovasculardiseaseriskmanagementamongpatientswithrheumatoidarthritislivinginsouthafricaanunequalmiddleincomecountry
AT anneestanwix pointstoconsiderincardiovasculardiseaseriskmanagementamongpatientswithrheumatoidarthritislivinginsouthafricaanunequalmiddleincomecountry
AT santoscastaneda pointstoconsiderincardiovasculardiseaseriskmanagementamongpatientswithrheumatoidarthritislivinginsouthafricaanunequalmiddleincomecountry
AT javierllorca pointstoconsiderincardiovasculardiseaseriskmanagementamongpatientswithrheumatoidarthritislivinginsouthafricaanunequalmiddleincomecountry
AT carlosgonzalezjuanatey pointstoconsiderincardiovasculardiseaseriskmanagementamongpatientswithrheumatoidarthritislivinginsouthafricaanunequalmiddleincomecountry
AT bridgethodkinson pointstoconsiderincardiovasculardiseaseriskmanagementamongpatientswithrheumatoidarthritislivinginsouthafricaanunequalmiddleincomecountry
AT benitharomela pointstoconsiderincardiovasculardiseaseriskmanagementamongpatientswithrheumatoidarthritislivinginsouthafricaanunequalmiddleincomecountry
AT mahmoodmtmally pointstoconsiderincardiovasculardiseaseriskmanagementamongpatientswithrheumatoidarthritislivinginsouthafricaanunequalmiddleincomecountry
AT ajeshbmaharaj pointstoconsiderincardiovasculardiseaseriskmanagementamongpatientswithrheumatoidarthritislivinginsouthafricaanunequalmiddleincomecountry
AT elsamvanduuren pointstoconsiderincardiovasculardiseaseriskmanagementamongpatientswithrheumatoidarthritislivinginsouthafricaanunequalmiddleincomecountry
AT joycejziki pointstoconsiderincardiovasculardiseaseriskmanagementamongpatientswithrheumatoidarthritislivinginsouthafricaanunequalmiddleincomecountry
AT mpotiseboka pointstoconsiderincardiovasculardiseaseriskmanagementamongpatientswithrheumatoidarthritislivinginsouthafricaanunequalmiddleincomecountry
AT makgotsomohapi pointstoconsiderincardiovasculardiseaseriskmanagementamongpatientswithrheumatoidarthritislivinginsouthafricaanunequalmiddleincomecountry
AT barendjjansenvanrensburg pointstoconsiderincardiovasculardiseaseriskmanagementamongpatientswithrheumatoidarthritislivinginsouthafricaanunequalmiddleincomecountry
AT garethstarr pointstoconsiderincardiovasculardiseaseriskmanagementamongpatientswithrheumatoidarthritislivinginsouthafricaanunequalmiddleincomecountry
AT kavitamakan pointstoconsiderincardiovasculardiseaseriskmanagementamongpatientswithrheumatoidarthritislivinginsouthafricaanunequalmiddleincomecountry
AT charlenebalton pointstoconsiderincardiovasculardiseaseriskmanagementamongpatientswithrheumatoidarthritislivinginsouthafricaanunequalmiddleincomecountry
AT aphroditegogakis pointstoconsiderincardiovasculardiseaseriskmanagementamongpatientswithrheumatoidarthritislivinginsouthafricaanunequalmiddleincomecountry
AT miguelagonzalezgay pointstoconsiderincardiovasculardiseaseriskmanagementamongpatientswithrheumatoidarthritislivinginsouthafricaanunequalmiddleincomecountry
AT patrickhdessein pointstoconsiderincardiovasculardiseaseriskmanagementamongpatientswithrheumatoidarthritislivinginsouthafricaanunequalmiddleincomecountry
_version_ 1724688787602145280
spelling doaj-c93769aa79ee4d97abc50cc901e11eaf2020-11-25T03:02:44ZengBMCBMC Rheumatology2520-10262020-06-014111610.1186/s41927-020-00139-2Points to consider in cardiovascular disease risk management among patients with rheumatoid arthritis living in South Africa, an unequal middle income countryAhmed Solomon0Anne E. Stanwix1Santos Castañeda2Javier Llorca3Carlos Gonzalez-Juanatey4Bridget Hodkinson5Benitha Romela6Mahmood M. T. M. Ally7Ajesh B. Maharaj8Elsa M. Van Duuren9Joyce J. Ziki10Mpoti Seboka11Makgotso Mohapi12Barend J. Jansen Van Rensburg13Gareth S. Tarr14Kavita Makan15Charlene Balton16Aphrodite Gogakis17Miguel A. González-Gay18Patrick H. Dessein19Rheumatology Department, Charlotte Maxeke Johannesburg Academic Hospital, Faculty of Health Sciences, University of WitwatersrandRheumatology Department, Charlotte Maxeke Johannesburg Academic Hospital, Faculty of Health Sciences, University of WitwatersrandRheumatology Department, Hospital de la Princesa, IIS-Princesa, Cátedra UAM-ROCHE, EPID-Future, Department of Medicine, Universidad Autónoma de Madrid (UAM)Universidad de Cantabria – IDIVAL, CIBER Epidemiologia y Salud Pública (CIBERESP)Cardiology Department, University Hospital Lucus AugustiRheumatology Department, University of Cape Town and Groote Schuur HospitalRheumatology Unit, Wilgeheuwel HospitalRheumatology Department, Steve Biko Academic Hospital, University of PretoriaRheumatology Unit, Westville Hospital and University of KwaZulu-NatalRheumatology Division, Department of Medicine, Sefako Makgatho Health Sciences UniversityRheumatology Department, Charlotte Maxeke Johannesburg Academic Hospital, Faculty of Health Sciences, University of WitwatersrandRheumatology Department, Charlotte Maxeke Johannesburg Academic Hospital, Faculty of Health Sciences, University of WitwatersrandRheumatology Department, Charlotte Maxeke Johannesburg Academic Hospital, Faculty of Health Sciences, University of WitwatersrandRheumatology Department, Universitas HospitalRheumatology Department, Tygerberg Hospital, Faculty of Health Sciences, Physiological Sciences Department, Stellenbosch UniversityRheumatology Department, Chris Hani Baragwanath HospitalRheumatology Department, Charlotte Maxeke Johannesburg Academic Hospital, Faculty of Health Sciences, University of WitwatersrandRadiology Unit, Rivonia Road Medical CentreCardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of WitwatersrandRheumatology Department, Charlotte Maxeke Johannesburg Academic Hospital, Faculty of Health Sciences, University of WitwatersrandAbstract Background It is plausible that optimal cardiovascular disease (CVD) risk management differs in patients with rheumatoid arthritis (RA) from low or middle income compared to high income populations. This study aimed at producing evidence-based points to consider for CVD prevention in South African RA patients. Methods Five rheumatologists, one cardiologist and one epidemiologist with experience in CVD risk management in RA patients, as well as two patient representatives, two health professionals and one radiologist, one rheumatology fellow and 11 rheumatologists that treat RA patients regularly contributed. Systematic literature searches were performed and the level of evidence was determined according to standard guidelines. Results Eighteen points to consider were formulated. These were grouped into 6 categories that comprised overall CVD risk assessment and management (n = 4), and specific interventions aimed at reducing CVD risk including RA control with disease modifying anti-rheumatic drugs, glucocorticoids and non-steroidal anti-inflammatory drugs (n = 3), lipid lowering agents (n = 8), antihypertensive drugs (n = 1), low dose aspirin (n = 1) and lifestyle modification (n = 1). Each point to consider differs partially or completely from recommendations previously reported for CVD risk management in RA patients from high income populations. Currently recommended CVD risk calculators do not reliably identify South African black RA patients with very high-risk atherosclerosis as represented by carotid artery plaque presence on ultrasound. Conclusions Our findings indicate that optimal cardiovascular risk management likely differs substantially in RA patients from low or middle income compared to high income populations. There is an urgent need for future multicentre longitudinal studies on CVD risk in black African patients with RA.http://link.springer.com/article/10.1186/s41927-020-00139-2Cardiovascular disease risk managementRheumatoid arthritisLow to middle income countriesSouth Africa